Phosphatidyl choline

N/A

Report date: 2023/10/05 20:00:39

Base Information

Drug NamePhosphatidyl choline
Drug Alias NamePhosphatidylcholine-richPhospholipid mixtureLP-02LT-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMucoproteins stimulants
TargetsMucoproteins
Therapy Area/IndicationsLocalized submental fatDiarrheaAbdominal Pain +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRomaniaGermany +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesUniversity Of Heidelberg
China Registration ClassN/A

Develop Information

Active CompaniesAmipharm Co LtdLipoid GmbhAscension South East Michigan +[4] 
Inactive CompaniesDr Falk Pharma GmbHLipid Therapeutics GmbhPrometheus Laboratories Inc
Active IndicationsLocalized submental fatTinnitusColitis, Ulcerative
Inactive IndicationsDiarrheaAbdominal Pain

Other Information

ATC CodeN/A
Related LinksN/A